Key statistics
On Thursday, Carisma Therapeutics Inc (W2J:FRA) closed at 0.889, 24.42% above the 52 week low of 0.7145 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.895 |
---|---|
High | 0.895 |
Low | 0.8865 |
Bid | -- |
Offer | -- |
Previous close | 0.889 |
Average volume | 1.21k |
---|---|
Shares outstanding | 41.54m |
Free float | 28.79m |
P/E (TTM) | -- |
Market cap | 41.54m USD |
EPS (TTM) | -1.78 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 14:29 BST.
More ▼
Press releases
- Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
- Carisma Therapeutics to Present at Upcoming Conferences
- Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024
- Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
- Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum
- Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors
More ▼